How to Buy Catalent Stock
Catalent Inc
Catalent is a pharmaceutical company located in New Jersey, United States, which is part of the Healthcare sector, and is traded under the ticker CTLT on the NYSE exchange.
Catalent stock last closed at $56.03, down 0.04% from the previous day, and has increased 24.68% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.34 percentage points. Catalent stock is currently +78.16% from its 52-week low of $31.45, and -6.93% from its 52-week high of $60.20.
There are currently 180.74M shares of CTLT outstanding. The market cap of CTLT is $10.13B. In the last 24 hours, 1.47M CTLT shares were traded.
How to Buy Catalent Stock
Not sure how to invest in Catalent stock? Here's how.
- Decide where to buy Catalent stock: You need to decide on an online brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you determine where to buy Catalent stock.
- Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit money your brokerage account: Pick your payment method and add your information.
- Research Catalent stock: The Catalent ticker symbol is CTLT. Is Catalent stock a good investment? Should you buy shares of CTLT? How do CTLT's underlying business fundamentals look? Do top analysts think Catalent is a good buy? Why has CTLT's stock price moved recently? (Hint: Our stock research tools can help you understand if CTLT is a good stock to buy).
- Execute your CTLT trade: Decide if you will purchase CTLT shares at the current market price or use a limit order to purchase CTLT shares at a specific price.
- Get updates on your CTLT position: Create a watchlist to important updates regarding your position in Catalent stock.
Step 1: Decide where to buy Catalent stock
You need an online brokerage account in order to access the NYSE market and buy CTLT shares.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
- Access to world markets: From Tech to Healthcare, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal info so you are able to buy CTLT stock today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal data to create your new trading account.
- Send your info by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you've created your account on one of the most highly reviewed stock apps, your next step is to transfer the money for your investment:
Check out this video walkthrough to see the process of transferring funds into your investment account.
Step 4: Research Catalent stock
Once you have identified the best place to buy Catalent stock, it's very important to evaluate their stock prior to investing, so you can understand the risk as well as the opportunity.
Catalent quick stats
Catalent Fundamentals
WallStreetZen was built to help average investors do better fundamental analysis quickly.
You can see all of the due diligence checks on CTLT's stock page.
Is CTLT stock undervalued or overvalued?
Investors use a variety of different financial metrics, analyses, models, and charts to gauge CTLT's intrinsic value.
Using relative valuations metrics:
- CTLT may be overvalued based on its P/B ratio of 2.75x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.07x
You can access additional valuation analysis on CTLT's stock here.
CTLT Financial Health
Pros:
- Total CTLT debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than short-term liabilities on the CTLT balance sheet.
Cons:
- CTLT profit margin has gone down from 8.2% to -31.8% in the past year.
- There are more long-term liabilities than short-term assets on the CTLT balance sheet.
- CTLT has a relatively high debt to equity ratio of 1.71.
- CTLT has $229.00M in cash and short term investments. This is not enough to cover its annual cash burn of $261.00M.
- CTLT has cash burn of 261000000. It does not have sufficient cash and short-term investments to cover this.
Do analysts think it's a good time to buy Catalent stock
Out of 6 Wall Street analysts who research CTLT, the consensus analyst rating on CTLT is a Hold
It's important to keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent CTLT Analyst Upgrades/Downgrades
Eric Coldwell, a top 19% analyst from Baird upgrades CTLT to a buy rating and raises their CTLT price target from $45.00 to $53.00, on Nov 16, 2023.
You can dive deeper into what analysts are forecasting on the Catalent stock forecast page.
CTLT Momentum
How is CTLT performing as a company?
Last year, CTLT revenue was $4.10B. In the past 5 year, CTLT's revenue has increased by 10.5% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 31.07%.
Dig into CTLT's earnings and revenue performance here.
Latest Insiders Trades at CTLT
In the last 12 months, insiders at CTLT have bought more shares than they have sold.
Scott Gunther, SVP Quality Reg. Affairs of CTLT, was the latest CTLT insider to sell. They sold $21,749.40 worth of CTLT shares on Mar 15, 2024.
Dig into more about who owns CTLT stock here.
Does CTLT stock generate passive income?
No, Catalent doesn't provide an income stream by paying out dividends.
What do other traders have to say about CTLT?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Execute your CTLT trade
There are two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best price on the market.
Market orders are mostly sufficient. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a particular dollar amount limit, use a limit order.
Press the Open button and eToro will place your order.
If you need additional help with investing in stocks on eToro, watch the helpful video below:
Step 6: Get updates on your CTLT position
Now that you own some CTLT stock, you'll want to stay up-to-date on your shares.
Create a watchlist to keep tabs on your CTLT stock.
CTLT Feed
How to Buy Stock in Catalent
To summarize, here are the 6 steps you need to take to buy Catalent stock right now:
- Decide where to buy Catalent stock
- Sign up for a brokerage account
- Deposit money your brokerage account
- Research Catalent stock
- Execute your CTLT trade
- Get updates on your CTLT position
If you require a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you would like to watch your new investment in Catalent, add CTLT to your watchlist by clicking the button below.
More Stock Buying Guides You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.